MDT

89

+0.34%↑

VEEV

283.53

+1.64%↑

A

121.36

+0.03%↑

WBA

11.55

+0.26%↑

HQY

99.19

-3.51%↓

MDT

89

+0.34%↑

VEEV

283.53

+1.64%↑

A

121.36

+0.03%↑

WBA

11.55

+0.26%↑

HQY

99.19

-3.51%↓

MDT

89

+0.34%↑

VEEV

283.53

+1.64%↑

A

121.36

+0.03%↑

WBA

11.55

+0.26%↑

HQY

99.19

-3.51%↓

MDT

89

+0.34%↑

VEEV

283.53

+1.64%↑

A

121.36

+0.03%↑

WBA

11.55

+0.26%↑

HQY

99.19

-3.51%↓

MDT

89

+0.34%↑

VEEV

283.53

+1.64%↑

A

121.36

+0.03%↑

WBA

11.55

+0.26%↑

HQY

99.19

-3.51%↓

Search

Maravai LifeSciences Holdings Inc (Class A)

Abrir

2.72 -0.73

Visão Geral

Variação de preço das ações

24h

Atual

Mín

2.51

Máximo

2.83

Indicadores-chave

By Trading Economics

Rendimento

-6.4M

-53M

Vendas

-9.6M

47M

Margem de lucro

-112.813

Funcionários

580

EBITDA

-28M

-49M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+76.92% upside

Dividendos

By Dow Jones

Próximos Ganhos

6 de ago. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

175M

950M

Abertura anterior

3.45

Fecho anterior

2.72

Pontuação Técnica

By Trading Central

Confiança

Bullish Evidence

Maravai LifeSciences Holdings Inc (Class A) Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

8 de jul. de 2025, 19:37 UTC

Grandes Movimentos do Mercado
Aquisições, Fusões, Aquisições de Empresas

M3-Brigade Shares Fall on Merger With ReserveOne

8 de jul. de 2025, 23:45 UTC

Conversa de Mercado

Gold Edges Lower, Weighed by Higher Treasury Yields -- Market Talk

8 de jul. de 2025, 23:42 UTC

Conversa de Mercado

Nikkei May Rise as Yen Weakens -- Market Talk

8 de jul. de 2025, 23:27 UTC

Conversa de Mercado

Australian REITs Yet to Offer Enough Appeal -- Market Talk

8 de jul. de 2025, 23:27 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

8 de jul. de 2025, 23:21 UTC

Conversa de Mercado

Summerset Bull Lauds Strong 2Q Sales Volumes -- Market Talk

8 de jul. de 2025, 23:21 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

8 de jul. de 2025, 22:29 UTC

Aquisições, Fusões, Aquisições de Empresas

Capricorn to Pay A$1.5 Million in Cash and Shares

8 de jul. de 2025, 22:28 UTC

Aquisições, Fusões, Aquisições de Empresas

Capricorn Metals Enters Binding Agreement to Buy Claw Gold Project

8 de jul. de 2025, 21:58 UTC

Conversa de Mercado

Kura Sushi Closely Watching U.S. Tariff Negotiations on Asian Goods -- Market Talk

8 de jul. de 2025, 20:50 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

8 de jul. de 2025, 20:50 UTC

Conversa de Mercado

Tech, Media & Telecom Roundup: Market Talk

8 de jul. de 2025, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

8 de jul. de 2025, 20:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

8 de jul. de 2025, 19:53 UTC

Conversa de Mercado

Copper Posts Biggest One-Day Gain Ever to Hit Record on Tariff Chatter -- Market Talk

8 de jul. de 2025, 19:53 UTC

Conversa de Mercado

Market Talk Roundup: Latest on U.S. Politics

8 de jul. de 2025, 19:45 UTC

Conversa de Mercado

Canada Unlikely to Succeed in Bid for Tariff-Free Trade With U.S. -- Market Talk

8 de jul. de 2025, 19:29 UTC

Conversa de Mercado

U.S. Consumer-Credit Growth Slowed in May -- Market Talk

8 de jul. de 2025, 19:20 UTC

Conversa de Mercado

U.S. Natural Gas Futures Settle Lower -- Market Talk

8 de jul. de 2025, 19:11 UTC

Conversa de Mercado

Bank of Canada's Rate Cuts Deliver Muted Relief Along the Curve -- Market Talk

8 de jul. de 2025, 19:01 UTC

Conversa de Mercado

Oil Futures Gain With Support From Products -- Market Talk

8 de jul. de 2025, 18:49 UTC

Ganhos

Hershey Names New CEO, Continuing Leadership Shuffle. The Stock Falls. -- Barrons.com

8 de jul. de 2025, 18:41 UTC

Conversa de Mercado

Mexico's Inflation Seen Mixed in June -- Market Talk

8 de jul. de 2025, 18:38 UTC

Conversa de Mercado

Gold Falls as Markets Digest Details of Trump Tariffs -- Market Talk

8 de jul. de 2025, 18:23 UTC

Conversa de Mercado

Analysts Anticipate Lower Ethanol Inventories -- Market Talk

8 de jul. de 2025, 18:10 UTC

Conversa de Mercado

Market Talk Roundup: Latest on U.S. Politics

8 de jul. de 2025, 18:10 UTC

Conversa de Mercado

Freeport-McMoRan Jumps on Trump Tariff Plan for Copper Imports -- Market Talk

8 de jul. de 2025, 17:24 UTC

Conversa de Mercado

Election, Dollar Seen as Potential Headwinds for Ibovespa -- Market Talk

8 de jul. de 2025, 17:06 UTC

Conversa de Mercado

KeyCorp and Regional Banks Set for a Catchup -- Market Talk

8 de jul. de 2025, 16:20 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

Comparação entre Pares

Variação de preço

Maravai LifeSciences Holdings Inc (Class A) Previsão

Preço-alvo

By TipRanks

76.92% parte superior

Previsão para 12 meses

Média 4.6 USD  76.92%

Máximo 7 USD

Mínimo 2 USD

Com base em 7 analistas de Wall Street que oferecem metas de preço de 12 meses para Maravai LifeSciences Holdings Inc (Class A) - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

7 ratings

4

Comprar

3

Manter

0

Vender

Pontuação Técnica

By Trading Central

2.02 / 2.115Suporte e Resistência

Curto Prazo

Bullish Evidence

Médio Prazo

Strong Bullish Evidence

Longo Prazo

No Evidence

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Maravai LifeSciences Holdings Inc (Class A)

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, and oligonucleotide building blocks, as well as custom enzyme development and manufacturing and CleanCap capping technology. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody, and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, viral clearance prediction kits, and custom services. The company serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. The company was incorporated in 2020 and is headquartered in San Diego, California.